Geographic · Long-Lived Assets

Rest of world — Long-Lived Assets

Eli Lilly Rest of world — Long-Lived Assets increased by 62.9% to $3.52B in Q4 2025 compared to the prior quarter.

Analysis

StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2023
Last reportedQ4 2025Feb 12, 2026
Rolls up toPP&E (Net)

How to read this metric

An increase suggests significant capital investment in international infrastructure to support future growth, whereas a decrease may indicate asset divestiture or a shift in the company's global operational strategy.

Detailed definition

This metric measures the book value of non-current, tangible, and intangible assets located in international geographic...

Peer comparison

Similar to 'Property, Plant, and Equipment' or 'Long-Lived Assets by Geography' reported by other multinational pharmaceutical companies.

Metric ID: lly_segment_rest_of_world_long_lived_assets

Historical Data

3 periods
 Q4 '23Q4 '24Q4 '25
Value$1.78B$2.16B$3.52B
QoQ Change+21.0%+62.9%
YoY Change+21.0%+62.9%
Range$1.78B$3.52B
Avg YoY Growth+41.9%
Median YoY Growth+41.9%
Current Streak2+ quarters growth

Frequently Asked Questions

What is Eli Lilly's rest of world — long-lived assets?
Eli Lilly (LLY) reported rest of world — long-lived assets of $3.52B in Q4 2025.
What does rest of world — long-lived assets mean?
The total value of the company's long-term physical and intangible assets located outside of its home country.